Clinical Trial Update: Phase I Dose Escalation in Patients With 1-3 Unresectable Brain Metastases [Phase 1]

View source ↗

Summary

A Phase I dose-escalation trial in patients with 1-3 unresectable brain metastases was withdrawn, according to ClinicalTrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Snippet

Sponsor: Barretos Cancer Hospital | Conditions: Brain Metastases | Phase 1 | Status: WITHDRAWN